M 1901 Valsartan |
|
| Click here for Typical Certificate of Analysis | |
| Solid | Please Inquire for Pricing |
| Screw cap v-vial | |
| M.W. 435.52 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
| MC 2487 Valsartan, [tetrazol-14C]- | |
| Click here for Typical Certificate of Analysis | |
|
MORpure™ HPLC purified, Delivered ≥ 98% pure with dated HPLC radiochromatogram
|
|
| Ethanol solution, 100 µCi/ml | |
| > 50 mCi(1.85 GBq)/mmol | 10 μCi (370 kBq) $1240 |
| NextGen V-Vial - shipped on dry ice | 50 μCi (1.85 MBq) $3970 |
| M.W. 435.52 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
| MT 2034 Valsartan, [3H]- | |
|
MORpure™
HPLC purified, Delivered ≥ 97% pure with dated HPLC radiochromatogram
|
|
| Ethanol solution, 1.0 mCi/ml | |
| > 0.5 Ci(18.5 GBq)/mmol | 50 µCi (1.85 MBq) $1670 |
| NextGen V-Vial - shipped on dry ice | 250 µCi (9.25 MBq) $2090 |
| M.W. 435.52 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |